ArticlePatient related outcome measures2019

A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial.

Koenraad Blot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.